Azithromycin for Child Survival in Niger: Delivery Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

10,925

Participants

Timeline

Start Date

June 28, 2021

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
MortalityChild HealthImplementation
Interventions
DRUG

Azithromycin for Oral Suspension

"Azithromycin will be administered as a single dose in oral suspension form for children as follows:~* Single-dose of 20mg/kg in children (up to the maximum adult dose of 1g)~* For children 1 to \<12 months of age, weight-based dosing will be used~* For children 12 to 59 months of age, height-based dosing will be used via height-stick approximation as currently performed by Niger's trachoma program."

Trial Locations (1)

Unknown

Program National de Santé Oculaire, Niamey

All Listed Sponsors
collaborator

Bill and Melinda Gates Foundation

OTHER

collaborator

Programme National de Santé Oculaire, Ministère de la Santé Publique du Niger

UNKNOWN

lead

University of California, San Francisco

OTHER